HomeCompareBUFGX vs JNJ

BUFGX vs JNJ: Dividend Comparison 2026

BUFGX yields 7.25% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BUFGX wins by $12.3K in total portfolio value
10 years
BUFGX
BUFGX
● Live price
7.25%
Share price
$31.58
Annual div
$2.29
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.3K
Annual income
$1,149.11
Full BUFGX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BUFGX vs JNJ

📍 BUFGX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBUFGXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BUFGX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BUFGX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BUFGX
Annual income on $10K today (after 15% tax)
$616.48/yr
After 10yr DRIP, annual income (after tax)
$976.74/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BUFGX beats the other by $273.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BUFGX + JNJ for your $10,000?

BUFGX: 50%JNJ: 50%
100% JNJ50/50100% BUFGX
Portfolio after 10yr
$26.2K
Annual income
$988.45/yr
Blended yield
3.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BUFGX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BUFGX buys
0
JNJ buys
0
No recent congressional trades found for BUFGX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBUFGXJNJ
Forward yield7.25%3.36%
Annual dividend / share$2.29$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$32.3K$20.0K
Annual income after 10y$1,149.11$827.78
Total dividends collected$9.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BUFGX vs JNJ ($10,000, DRIP)

YearBUFGX PortfolioBUFGX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,425$725.27$10,676$355.77+$749.00BUFGX
2$12,999$774.43$11,407$389.39+$1.6KBUFGX
3$14,733$823.49$12,198$426.53+$2.5KBUFGX
4$16,636$872.24$13,056$467.62+$3.6KBUFGX
5$18,722$920.50$13,987$513.12+$4.7KBUFGX
6$21,000$968.10$14,998$563.56+$6.0KBUFGX
7$23,485$1,014.89$16,098$619.52+$7.4KBUFGX
8$26,190$1,060.73$17,295$681.69+$8.9KBUFGX
9$29,128$1,105.50$18,599$750.82+$10.5KBUFGX
10$32,317$1,149.11$20,022$827.78+$12.3KBUFGX

BUFGX vs JNJ: Complete Analysis 2026

BUFGXStock

The fund invests in common stocks and other equity securities, including preferred stock, convertible securities, warrants and rights, with a goal of maintaining at least 75% of the fund’s portfolio in companies with market capitalizations greater than the median of the Russell 3000® Growth Index or $5 billion, whichever is lower.

Full BUFGX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BUFGX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BUFGX vs SCHDBUFGX vs JEPIBUFGX vs OBUFGX vs KOBUFGX vs MAINBUFGX vs ABBVBUFGX vs MRKBUFGX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.